Clinical Trial Update: A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine [Phase 3]

View source ↗

Summary

A Phase 3 double-blind, placebo-controlled trial to evaluate the efficacy and safety of frovatriptan in acute treatment of migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Migraine | Phase 3 | Status: COMPLETED